Pfizer Inc.
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
Last updated:
Abstract:
Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
Status:
Grant
Type:
Utility
Filling date:
16 Jan 2020
Issue date:
29 Sep 2020